Haverford Financial Services, Inc. Amgen Inc Transaction History

Haverford Financial Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $756,742 - $886,615	-3,565 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $360,881 - $400,371	-1,545 Reduced 30.23%	3,565 $869,000
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $168,776 - $200,982	-780 Reduced 13.24%	5,110 $1.18 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $1.07 Million - $1.42 Million	5,890 New	5,890 $1.19 Million

3,120

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Haverford Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Haverford Financial Services, Inc. with notifications on news.